27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Aptevo Therapeutics Inc (NASDAQ:APVO) shares are trading higher on Tuesday, after the company announced it regained compliance with the NASDAQ listing requirements.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Aptevo Therapeutics is a clinical-stage biotechnology company, engages in the discovery, development, commercialization, and sale of novel oncology and hematology therapeutics in the U.S.
Aptevo Therapeutics shares were trading 8.24% higher at $4.07 on Tuesday. The stock has a 52-week high of $14.56 and a 52-week low of 27 cents.